PADRE Research Review: A Certificate for Every Product, Behind a Free Account
An independent PADRE Research review: eight peptides, eight ILS Laboratories certificates, every lot verified twice — against a business four months old, one batch deep, with prices behind a login.
Most vendors publish some certificates. PADRE Research publishes one for every product it sells — and then puts the list behind a login, which is an unusual way to treat your best asset.
Reviewed September 18, 2026. PeptideBenchmark has no affiliate, referral, coupon, sponsorship, or paid-placement relationship with PADRE Research. The vendor sells research-use-only products; this is a commercial-transparency and documentary-evidence review, not human-use guidance or medical advice.
Every product has a certificate and every certificate checks out at the laboratory as well as on the vendor's site. The limits are time and reach, not documentation: one batch series, a business a few months old, no review history, and an accreditation that does not cover peptide work.
The short version
PADRE sells eight peptides. All eight have a certificate of analysis from ILS Laboratories, and we verified each one along the full chain rather than taking the vendor’s copy at face value:
- Fetch the certificate PADRE serves from its own storage — no account needed once you have the link.
- Read the access code printed on that certificate.
- Resolve the code at ILS Laboratories’ own public portal.
- Confirm the laboratory returns the same report, under the client name Padre Research.
All eight passed. The laboratory’s copy is byte-identical to the vendor’s, which is the cleanest possible outcome: PADRE is republishing the lab’s document unmodified rather than producing its own rendering.
| Product | Lot | Purity | Labeled → measured | Price |
|---|---|---|---|---|
| RT-3 (retatrutide) | PR-RT15-B1-0626-1 | 99.91% | 15mg → 15.62mg | $69 |
| TRZ-2 (tirzepatide) | PR-TRZ10-B1-0626-1 | 99.90% | 10mg → 10.71mg | $49 |
| GHK-Cu | PR-GHK50-B1-0626-1 | 99.87% | 50mg → 52.81mg | $35 |
| Ipamorelin | PR-IPA10-B1-0626-1 | 99.85% | 10mg → 10.50mg | $39 |
| CJC-1295 no DAC | PR-CJC10-B1-0626-1 | 99.80% | 10mg → 10.48mg | $65 |
| MOTS-c | PR-MOT10-B1-0626-1 | 99.79% | 10mg → 10.43mg | $45 |
| BPC-157 | PR-BPC10-B1-0626-1 | 99.46% | 10mg → 10.65mg | $39 |
| TB-500 | PR-TB510-B1-0626-1 | 99.13% | 10mg → 10.51mg | $55 |
Every report carries the same panel: HPLC purity and identity, a fentanyl screen at a 50 ng/mL immunoassay cutoff, heavy metals by ICP-MS, sterility by PCR, and a quantitative endotoxin result per USP <85>. Every result passes or sits within normal ranges. Measured content runs slightly over label on all eight, which is the direction you would rather see.
One detail worth stating plainly, because it invites a wrong conclusion: the endotoxin line has a specification of “Report Result,” not a numeric limit. Three reports print NMT 0.05 EU/mL and the retatrutide report prints 0.08 EU/mL, each marked Reported. The certificate explains why — acceptable endotoxin limits vary by product type and matrix, so no universal threshold applies to research-use material. None of these is a specification failure.
The accreditation needs one qualification
PADRE’s public pages say every batch goes to “ILS Laboratories, an ISO/IEC 17025-accredited independent lab,” and the certificates carry an “ISO/IEC 17025 Accredited” footer. ILS is genuinely accredited — PJLA, ISO/IEC 17025:2017, Accreditation No. 112120, Certificate No. L25-631, valid through 2027-08-31, issued to “ILS Labs, Inc. dba Quality Cannabis Laboratories” at the same San Diego address printed on PADRE’s COAs.
That accreditation’s scope is cannabis and hemp testing. It does not cover peptide analysis. The scope supplement lists cannabis plant material, concentrates, infused products and hemp flower; HPLC-UV appears there for cannabinoid potency and ICP-MS for heavy metals in cannabis goods.
This is not specific to PADRE and it is not an accusation of dishonesty — ILS is a real accredited laboratory used across this market, and PeptideBenchmark records its status the same way everywhere. But “ISO/IEC 17025-accredited lab” invites readers to assume the accreditation covers the test in front of them, and here it does not. Read these as results from a competent commercial laboratory, not as accredited-scope peptide analysis.
What the account gets you, and what it costs
Prices and the certificate index require a free researcher account — request a magic link by email or sign in with Google, then accept a research-use attestation. There is no fee and no order-history requirement.
Once inside: eight peptides from $35 to $69 a vial, with multi-vial packs bringing GHK-Cu to $26.67 per vial and retatrutide to $55. Four products were on a dated promotion when we looked (BPC-157 $55→$39, Ipamorelin $49→$39, RT-3 $95→$69, GHK-Cu $45→$35), so the board figures are a snapshot, not a standing quote. There is also a separate subscribe price that is sometimes higher than the one-time price; PeptideBenchmark compares one-time purchases only.
The cost of that arrangement is discoverability. A reader comparing vendors cannot see PADRE’s prices or its certificate list without signing up, and search engines cannot index either. A vendor with complete certificate coverage is, in effect, keeping its strongest argument behind a form.
The business behind it
PADRE Research is new, and the record is consistent about it. The domain was registered May 17, 2026; PADRE Research LLC was filed with Florida on June 17, 2026; every certificate carries a B1-0626 stamp. The About page, written in the first person by a founder who signs as Angel, says the operation is “small on purpose,” and on the evidence that is literally true.
The published address — 13833 Wellington Trace, Ste E4 #646, Wellington, FL — is a private mailbox in a retail plaza. That is unremarkable in this trade, and one point in the vendor’s favour: it is the same address on the state filing, where it serves as principal, mailing and registered-agent address. Plenty of storefronts publish a mailbox that matches nothing on file.
There is no Trustpilot profile, essentially no community discussion, and no adverse listing on the scam and fake-vendor lists we checked. For a four-month-old business that is expected rather than alarming, but it does mean the certificates are carrying the entire weight of the case.
Commercial terms as published: US-only shipping via FedEx or UPS (never USPS), dispatch typically in 1–2 business days, 3–5 business day domestic delivery, flat $12 shipping with free delivery at $250, card and crypto, all sales final. Purchase is limited to United States residents attesting to qualified-researcher status. The research-use compliance policy is more substantive than most.
What would move this further
The documentation is already strong; what is missing is time and reach. A second batch series would show whether the standard holds. A public certificate page — the same documents, just linked where anyone can find them — would let readers verify PADRE without an account and let this record be indexed. And a laboratory whose accreditation scope covers peptide analysis would close the one real gap between what the certificates say and what the accreditation badge implies.
Checking it yourself
- The vendor’s site: padreresearch.com
- PADRE’s live PeptideBenchmark profile: /vendors/padre-research/
- Its certificates in the public archive: COA database
- How our scores are built: scoring methodology
The access code is printed on every PADRE certificate. If you hold one of their vials, that code resolves at the laboratory’s portal the same way these eight did — you do not have to take the vendor’s word for it, and you do not have to take ours.
Common questions
Does PADRE Research publish COAs?
Yes, for every product. All eight peptides in the catalog carry a certificate of analysis from ILS Laboratories, and PeptideBenchmark verified each one twice — the copy PADRE serves from its own storage, and the same report resolved at the laboratory's public portal using the access code printed on the certificate. Every lot resolves under the client name Padre Research, and the two copies are byte-identical. The certificate index sits behind a free researcher account, but the certificate documents themselves are served publicly.
Is PADRE Research legitimate?
PeptideBenchmark does not issue binary legitimacy or product-safety endorsements. What is checkable: PADRE Research LLC is an active Florida company, and all eight of its peptides carry an independently verifiable certificate reporting 99.13% to 99.91% purity with confirmed identity, a clean fentanyl screen, heavy metals within limits, and no sterility growth. That is a stronger documentary record than most vendors we review. It is also one batch deep, from a business a few months old, so there is no track record showing whether later batches hold that standard.
Is ILS Laboratories ISO/IEC 17025 accredited for peptide testing?
ILS is accredited, but not for this. Its ISO/IEC 17025:2017 accreditation from PJLA (Accreditation No. 112120, Certificate No. L25-631, valid through 2027-08-31) is issued to ILS Labs, Inc. dba Quality Cannabis Laboratories, and its scope supplement covers cannabis and hemp testing. Peptide purity, sterility and endotoxin analysis fall outside that scope. PADRE's claim that it uses an ISO/IEC 17025-accredited lab is accurate about the laboratory; it should not be read as meaning the accreditation covers the peptide panel on the certificate. This applies to every vendor using ILS, not only PADRE.
How much does PADRE Research cost?
At the September 18, 2026 observation: GHK-Cu 50mg $35, BPC-157 10mg $39, Ipamorelin 10mg $39, MOTS-c 10mg $45, TRZ-2 10mg $49, TB-500 10mg $55, CJC-1295 no DAC 10mg $65, and RT-3 15mg $69, with multi-vial packs down to $26.67 per vial on GHK-Cu. Four of those were on a dated promotion. Prices are visible only after creating a free account, so treat them as a dated observation rather than a standing quote.
How old is PADRE Research?
New. The domain padreresearch.com was registered on May 17, 2026, PADRE Research LLC was filed with the Florida Division of Corporations on June 17, 2026, and every certificate carries a B1-0626 batch stamp — batch one, June 2026. The vendor's own About page describes the operation as 'small on purpose.'
Does PeptideBenchmark have an affiliate relationship with PADRE Research?
No. At the time of this review, PeptideBenchmark had no affiliate, referral, coupon, sponsorship, or paid-placement relationship with PADRE Research, and found no public affiliate program operated by the vendor.